Parkinson’s disease, paralysis agitans, is a neurodegenerative disease of the substantia nigra of the brain. The disease was first discovered and its symptoms documented in 1817-Essay on the Shaking Palsy, by the British physician Dr. James Parkinson; the associated biochemical changes in the brain of patients were identified in the 1960s.
Researchers showed that therapeutic cloning or SCNT has been successfully used to treat disease in the same subjects from whom the initial cells were derived. – Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson’s disease in mice.
The Parkinson?s Disease Society (PD) has announced funding of ?170k to the University of Bristol for research into how to make stem cells produce dopamine and live longer after they have been transplanted into animals. – The Parkinson’s Disease Society (PD) has announced funding of ?170k to the University of Bristol for research into how to make stem cells produce dopamine and live longer after they have been transplanted into animals.
People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology. – Parkinson’s disease risk is reduced in people taking drugs known as calcium channel blockers to treat high blood pressure, revealed by researchers in US.
